miR‑30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy

Xinming Du(Shandong University), Leping Li(Shandong University)

Experimental and Therapeutic Medicine

October 23, 2017

10.3892/etm.2017.5354

Cited by 64

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A novel 3’tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer

|Cell Death and Disease|2022|99

miR-135b-5p promotes gastric cancer progression by targeting CMTM3

|International Journal of Oncology|2017|57

microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases

|Experimental and Therapeutic Medicine|2015|50

Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs Open Surgery

|JAMA Network Open|2022|49